• About online consultations

  • 30 Consultation


  • 60 Consultation

  • 30 min Review & 30 min Consultation
    ※Online consultation will be in the latter 30 minutes.
    ※Please send the manuscript by 2-5 days prior to the date of the session(consult@enago.com)

Joe Barber

Country: Memphis, United States of America


Qualification: Ph.D. in Pharmacology; University of Michigan



Communication style

Experienced mentor, will speak slow in easy English, and has interacted with ESL researchers.


  1. Instructor profile
Joe obtained his Ph.D. from the reputed University of Michigan at Ann Arbor. His work has been duly recognized with several awards. Joe is a published author and he has presented his work at various conferences as well. Joe has received more than 10 awards between 1995 and 2005 for his scholastic achievements. He has also been closely associated with over 15 reputed organizations including the American Association for the Advancement of Science.
  • Has won several awards in the field of cancer research.
  • Has presented at least 15 posters and oral papers in international conferences.
  • Has mentored middle and high school students interested in careers in health and medical research.
  • Has conducted scientific demonstrations, laboratory tours, and demonstrations of experimental techniques.
  • Has advised students on many topics, including college applications, career options, and study habits.
  • Has written news articles on Science and Medicine for online publications.
Education
  • PhD Pharmacology | 2000-2007
  • Department of Pharmacology, University of Michigan, Ann Arbor, MI
  • Advisor-Dr. Donna S. Shewach
  • Thesis Title-The Effects of p53R2 on Gemcitabine-Mediated Cytotoxicity and Radiosensitization
  • B.S. Microbiology | 1995-1999
  • Department of Biological Sciences, Southern University and A&M College, Baton Rouge, LA
  • Advisor-Dr. Bryan A. Lewis
  • Thesis Title-Chlamydia: Cause, Treatment, and Prevention
Awards
  • 2005 | American Association for Cancer Research Minority Scholar Award
  • 2004 | American Association for Cancer Research Minority Scholar Award
  • 2003 | American Association for Cancer Research Minority Scholar Award
  • 2000 | Rackham Graduate School Merit Fellow, University of Michigan
  • 1999 | Highest Graduating GPA, College of Sciences, Southern University
  • 1999 | Magna cum Laude Graduate, Southern University
  • 1998 | Inducted, Beta Kappa Chi National Scientific Honor Society
  • 1998 | Inducted, Beta Beta Beta National Biological Honor Society
  • 1997 | Inducted, Golden Key National Honor Society
  • 1997-1999 | Louisiana Association for Minority Participation Scholar
  • 1995-1999 | Chancellor’s Scholar, Southern University
  • 1995-1999 | Dean’s List, Southern University
Organizations
  • 2011- American Medical Writers Association
  • 2009- American Association for the Advancement of Science
  • 2008- International Society for the Study of Xenobiotics
  • 2007- National Postdoctoral Association
  • 2007-2009 St Jude Postdoctoral Association
  • 2002- American Association for Cancer Research
  • 2000-2007 Association of Multicultural Scientists, University of Michigan
  • 2000-2007 Students of Color at Rackham, University of Michigan
  • 1998-1999 Southern University Microbiology Club
  • 1998- Beta Kappa Chi National Scientific Honor Society
  • Served as Southern University Chapter President 1998-1999
  • 1998- Beta Beta Beta National Biological Honor Society
  • Served as Vice President 1999-2000, Southeast Region, District II
  • 1997- Golden Key National Honor Society
  • 1997-1999 Louisiana Association for Minority Participation
  • 1995-1999 Southern University Honors College
Selected Publications
  • Barber Jr., Joe. EU approves AstraZeneca’s Fasenra for severe eosinophilic asthma. FirstWord Pharma. January 10, 2018.
  • Barber Jr., Joe. Nestlé emerges as lead in bid for Merck KGaA’s consumer-health unit: report. FirstWord Pharma. January 10, 2018.
  • Barber Jr., Joe. GlaxoSmithKline to have replaced 40 percent of management team: report. FirstWord Pharma. January 9, 2018
  • Barber Jr., Joe. Axovant ends development of intepirdine after dementia mid-stage study failure. FirstWord Pharma. January 8, 2018.
  • Barber Jr., Joe. Axovant ends development of intepirdine after dementia mid-stage study failure. FirstWord Pharma. December 21, 2017.
  • Barber Jr., Joe. US President Donald Trump nominates ex-Eli Lilly executive Alex Azar as health secretary. FirstWord Pharma. November 13, 2017.
  • Barber Jr., Joe. Gilead gains foothold in CAR-T therapies with $11.9-billion deal for Kite Pharma. FirstWord Pharma. August 28, 2017.
  • Barber Jr., Joe. Scott Gottlieb confirmed by US Senate to head FDA. FirstWord Pharma. May 9, 2017.
  • Barber Jr., Joe. FDA panel unanimously backs approval of Novartis’ proposed biosimilar of Amgen’s Enbrel. FirstWord Pharma. July 13, 2016.
  • Barber Jr., Joe. US appeals court invalidates patent for Teva’s Copaxone, allowing launch of Novartis, Momenta’s generic. FirstWord Pharma. June 18, 2015.
  • Barber Jr., Joe. Study suggests that cost to develop, launch new drug is nearly $2.6 billion. FirstWord Pharma. November 18, 2014.
  • Barber Jr., Joe. Report: Roche preparing a $10-billion bid for full stake in Chugai. August 15, 2014.
  • Barber Jr., Joe. Amgen’s trebananib meets main goal of Phase III ovarian cancer trial. FirstWord Pharma. June 12, 2013.
  • Barber Jr., Joe, Nghiem Hien T Guidelines for Diagnosis of Asymptomatic Microhematuria. Medscape Medical News. WebMD LLC. November 20, 2012
  • Barber Jr., Joe. Salt Content Variable in Fast Food in Different Countries. Medscape Medical News. WebMD LLC. April 16, 2012.
  • Barber Jr., Joe. Chronic Urticaria Increases Cancer Risk. Medscape Medical News. WebMD LLC. January 20, 2012.
  • Barber Jr., Joe. Roux-en-Y Gastric Bypass Superior to Gastric Banding. Medscape Medical News. WebMD LLC. January 18, 2012.
  • Barber Jr., Joe, Murata, Penny. Glucagon-Like Peptide-1 Receptor Agonists Promote Weight Loss. Medscape Education. WebMD LLC. January 18, 2012.
  • Barber Jr., Joe. UK Research Misconduct May Be Underreported. Medscape Medical News. WebMD LLC. January 17, 2012.
  • Barber Jr., Joe, Lie, Désirée. Primary Care Attributes Linked With Patient Mortality Rates. Medscape Education. WebMD LLC. January 17, 2012.
  • Barber Jr., Joe. Public Citizen Requests Recall of the Wingspan Stent. Medscape Medical News. WebMD LLC. January 4, 2012.
  • Barber Jr., Joe, Lie, Désirée. Aggressive Feeding Strategy Effective in Patients With Anorexia. Medscape Education. WebMD LLC. January 3, 2012.
  • Barber Jr., Joe. Vitamin D and Calcium Supplementation Reduces Fracture Risk. Medscape Medical News. WebMD LLC. December 19, 2011.
  • Barber Jr., Joe. Patient-Centered Approach May Improve Glycemic Control in Diabetes. Medscape Medical News. WebMD LLC. December 14, 2011.
  • Barber Jr., Joe, Murata, Penny. Mothers and Infants Protected From H1N1 With Single-Dose Vaccine. Medscape Education. WebMD LLC. December 14, 2011.
  • Barber Jr., Joe. Acute Kidney Injury and Its Risks Common for Those in Combat. Medscape Medical News. WebMD LLC. December 8, 2011.
  • Barber Jr., Joe, Lie, Désirée. Refractive Error Strongly Predicts Childhood Strabismus. Medscape Education. WebMD LLC. December 6, 2011.
  • Barber Jr., Joe. CE Mark Approval Secured for Victus Femtosecond Laser. Medscape Medical News. WebMD LLC. December 6, 2011.
  • Barber Jr., Joe. Home Birth Adverse Events Rare in Low-Risk Pregnancies. Medscape Medical News. WebMD LLC. November 30, 2011.
  • Barber Jr., Joe. Patient-Centered Approach May Improve Glycemic Control in Diabetes. Medscape Education. WebMD LLC. November 30, 2011.
  • Barber Jr., Joe. Routine Imaging Could Reduce the Number of Standard Autopsies. Medscape Medical News. WebMD LLC. November 21, 2011.
  • Barber Jr., Joe. Direct/Conjugated Bilirubin Predicts Biliary Atresia. Medscape Medical News. WebMD LLC. November 21, 2011. Web.
  • Lin, Yvonne S, Yasuda, Kazuto, Assem, Mahfoud, Cline, Cynthia, Barber Jr., Joe, Li, Chia-Wei, Kholodovych, Vladyslav, Ai, Ni, Chen, J. Don., Welsh, William J, Schuetz, Erin G. The major human PXR splice variant, PXR.2, exhibits significantly diminished ligand-activated transcriptional regulation. Drug Metabolism and Disposition, 2009.
Oral Presentations
  • Barber Jr., Joe. PXR and FoxA2: The Intersection of Drug Metabolism and Energy Homeostasis Pathways. St. Jude Children’s Research Hospital, Memphis, TN 2008.
  • Barber Jr., Joe. Transcriptional Regulation of PXR by FoxA2. St Jude Children’s Research Hospital, Memphis, TN 2008.
  • Barber Jr., Joe. The Effects of p53R2 Expression of Gemcitabine-Mediated Cytotoxicity and Radiosensitization. Tennessee State University, Nashville, TN, 2007.
  • Barber Jr., Joe. The Effects of p53 and p53R2 Expression on Gemcitabine-mediated Cytotoxicity and Radiosensitization. St. Jude Children’s Research Hospital, Memphis, TN, 2006
  • Barber Jr., Joe. Induction of p53R2 by Gemcitabine and/or Ionizing Radiation and the Resulting Effects on Radiosensitization. University of Michigan, Ann Arbor, MI, 2004.
  • Barber Jr., Joe. The Effects of High Dose Gemcitabine on p53 Expression and Radiosensitization in MCF-7 Breast Cancer Cells. University of Michigan, Ann Arbor, MI, 2003.
Communications
  • Barber Jr., Joe, Yasuda, Kazuto, Lamba, Jatinder K, Lan, Lubin, Schuetz, Erin G. Transcriptional Regulation of PXR by FoxA2. International Society for the Study of Xenobiotics 11th Annual North American Meeting: Receptors/Nuclear Receptors, San Diego CA 2008. Poster Presentation.
  • Barber Jr., Joe, Shewach, Donna S. siRNA for p53R2 inhibits increases in p53R2 expression following exposure to DNA damaging agents. American Association for Cancer Research 97th Annual Meeting: Experimental and Molecular Therapeutics 45, Washington, DC 2006. Poster Presentation.
  • Barber Jr., Joe, Ostruszka, Leo J., Shewach, Donna S. The Effects of dFdCyd and Ionizing Irradiation on p53R2 and R2 Expression During the Cell Cycle. Gordon Research Conference on Purines, Pyrimidines, and Related Substances, Newport RI 2005. Poster Presentation
  • Barber Jr., Joe, Ostruszka, Leo J., Shewach, Donna S. The Effects of dFdCyd and Ionizing Irradiation on p53R2 and R2 Expression During the Cell Cycle. American Association for Cancer Research 96th Annual Meeting: Experimental and Molecular Therapeutics 17, Anaheim, Orange County, CA 2005. Poster Presentation.
  • Barber Jr., Joe, Im, Mike M, Shewach, Donna S. Induction of p53R2 by dFdCyd Does Not Prevent R2 Expression. American Association for Cancer Research 95th Annual Meeting: Experimental and Molecular Therapeutics 26, Orlando FL 2004. Poster Presentation.
  • Barber Jr., Joe, Robinson, Blaine W, Shewach, Donna S. Expression of p53R2 Does Not Prevent dATP Depletion or Radiosensitization with dFdCyd in Wild-Type p53-Expressing Cells. Gordon Research Conference on Nucleosides, Nucleotides, and Oligonucleotides, Newport RI 2003. Poster Presentation.
  • Barber Jr., Joe, Robinson, Blaine W, Shewach, Donna S. Expression of p53R2 Does Not Prevent dATP Depletion or Radiosensitization with dFdCyd in Wild-Type p53-Expressing Cells. American Association for Cancer Research 94th Annual Meeting: Cellular, Molecular, and Tumor Biology 93, Washington, DC 2003. Poster Presentation
  • Barber Jr., Joe, Robinson, Blaine W., Ostruszka, Leo J., Shewach, Donna S. The Effects of Gemcitabine on p53 Expression, Cell Cycle Progression, and Radiosensitization in MCF-7 Breast Cancer Cells. Department of Pharmacology/Phizer Poster Day, Ann Arbor, MI, 2002. Poster Presentation.
  • Barber Jr., Joe, Robinson, Blaine W., Ostruszka, Leo J., Shewach, Donna S. The Effects of Gemcitabine on p53 Expression, Cell Cycle Progression, and Radiosensitization in MCF-7 Breast Cancer Cells. Pharmacology Research Colloquium, Toledo, OH 2002. Poster Presentation.
  • Barber Jr., Joe, Robinson, Blaine W., Ostruszka, Leo J., Shewach, Donna S. The Effects of Gemcitabine on p53 Expression, Cell Cycle Progression, and Radiosensitization in MCF-7 Breast Cancer Cells. American Association for Cancer 93rd Annual Meeting: Experimental/Molecular Therapeutics 33, San Francisco, CA, 2002. Poster Presentation

Read More >> Read Less >>

Book an Appointment

Consultation

$49 | 30 minutes

Consultation

$89 | 60 minutes

30 min Review & 30 min Consultation

$89 | 30 minutes